USD 97.13
(-1.89%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 891.35 Million USD | 231.67% |
2022 | 268.75 Million USD | -14.69% |
2021 | 315.02 Million USD | -27.59% |
2020 | 435.06 Million USD | -16.93% |
2019 | 523.74 Million USD | 32.54% |
2018 | 395.15 Million USD | 41.9% |
2017 | 278.47 Million USD | -14.15% |
2016 | 324.37 Million USD | 56.25% |
2015 | 207.59 Million USD | -7.53% |
2014 | 224.49 Million USD | -9.79% |
2013 | 248.85 Million USD | 4.75% |
2012 | 237.56 Million USD | 672.9% |
2011 | 30.73 Million USD | -62.3% |
2010 | 81.53 Million USD | 1064.83% |
2009 | 7 Million USD | 1802.17% |
2008 | 368 Thousand USD | -12.38% |
2007 | 420 Thousand USD | 104.88% |
2006 | 205 Thousand USD | 5025.0% |
2005 | 4000.00 USD | -66.67% |
2004 | 12 Thousand USD | -28.11% |
2003 | 16.69 Thousand USD | -96.0% |
2002 | 416.87 Thousand USD | -93.41% |
2001 | 6.32 Million USD | -74.8% |
2000 | 25.1 Million USD | -25.06% |
1999 | 33.5 Million USD | 161.72% |
1998 | 12.8 Million USD | 24.27% |
1997 | 10.3 Million USD | -3.74% |
1996 | 10.7 Million USD | 27.38% |
1995 | 8.4 Million USD | 82.61% |
1994 | 4.6 Million USD | 100.0% |
1993 | 2.3 Million USD | 130.0% |
1992 | 1 Million USD | 900.0% |
1991 | 100 Thousand USD | 0.0% |
1990 | - USD | -100.0% |
1989 | 200 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 750.5 Million USD | -5.96% |
2024 Q1 | 872.74 Million USD | -2.09% |
2024 Q2 | 871.1 Million USD | -0.19% |
2023 FY | 891.35 Million USD | 231.67% |
2023 Q4 | 891.35 Million USD | 150.9% |
2023 Q1 | 266.46 Million USD | -0.85% |
2023 Q2 | 407.11 Million USD | 52.78% |
2023 Q3 | 355.26 Million USD | -12.74% |
2022 FY | 268.75 Million USD | -14.69% |
2022 Q2 | 316.1 Million USD | -2.18% |
2022 Q4 | 268.75 Million USD | -6.35% |
2022 Q3 | 286.96 Million USD | -9.22% |
2022 Q1 | 323.15 Million USD | 2.58% |
2021 Q2 | 369.96 Million USD | -7.65% |
2021 FY | 315.02 Million USD | -27.59% |
2021 Q4 | 315.02 Million USD | -10.83% |
2021 Q3 | 353.3 Million USD | -4.5% |
2021 Q1 | 400.6 Million USD | -7.92% |
2020 FY | 435.06 Million USD | -16.93% |
2020 Q1 | 528.94 Million USD | 0.99% |
2020 Q4 | 435.06 Million USD | -1.05% |
2020 Q3 | 439.7 Million USD | -11.19% |
2020 Q2 | 495.08 Million USD | -6.4% |
2019 Q4 | 523.74 Million USD | 0.02% |
2019 Q1 | 468.25 Million USD | 18.5% |
2019 Q3 | 523.66 Million USD | 8.37% |
2019 Q2 | 483.22 Million USD | 3.2% |
2019 FY | 523.74 Million USD | 32.54% |
2018 Q4 | 395.15 Million USD | 89.19% |
2018 Q2 | 413.56 Million USD | 6.99% |
2018 Q3 | 208.86 Million USD | -49.5% |
2018 Q1 | 386.53 Million USD | 38.8% |
2018 FY | 395.15 Million USD | 41.9% |
2017 Q2 | 241.91 Million USD | 1.9% |
2017 Q4 | 278.47 Million USD | 0.19% |
2017 FY | 278.47 Million USD | -14.15% |
2017 Q1 | 237.4 Million USD | -26.81% |
2017 Q3 | 277.94 Million USD | 14.89% |
2016 Q2 | 231.71 Million USD | 1.45% |
2016 Q1 | 228.4 Million USD | 10.02% |
2016 Q3 | 327.76 Million USD | 41.45% |
2016 FY | 324.37 Million USD | 56.25% |
2016 Q4 | 324.37 Million USD | -1.03% |
2015 Q4 | 207.59 Million USD | -1.25% |
2015 Q1 | 212.87 Million USD | -5.17% |
2015 FY | 207.59 Million USD | -7.53% |
2015 Q3 | 210.21 Million USD | 0.21% |
2015 Q2 | 209.77 Million USD | -1.46% |
2014 FY | 224.49 Million USD | -9.79% |
2014 Q4 | 224.49 Million USD | -6.77% |
2014 Q3 | 240.8 Million USD | -3.05% |
2014 Q2 | 248.37 Million USD | -2.38% |
2014 Q1 | 254.44 Million USD | 2.25% |
2013 Q3 | 251.15 Million USD | -2.21% |
2013 Q4 | 248.85 Million USD | -0.92% |
2013 FY | 248.85 Million USD | 4.75% |
2013 Q1 | 254.25 Million USD | 7.02% |
2013 Q2 | 256.82 Million USD | 1.01% |
2012 Q4 | 237.56 Million USD | 227.22% |
2012 FY | 237.56 Million USD | 672.9% |
2012 Q2 | 64.68 Million USD | 7.42% |
2012 Q1 | 60.21 Million USD | 77.3% |
2012 Q3 | 72.6 Million USD | 12.24% |
2011 Q2 | 55 Million USD | -33.39% |
2011 Q4 | 33.96 Million USD | 504.43% |
2011 FY | 30.73 Million USD | -62.3% |
2011 Q1 | 82.56 Million USD | -0.37% |
2011 Q3 | 5.61 Million USD | -89.78% |
2010 Q3 | 87.98 Million USD | 33355.89% |
2010 FY | 81.53 Million USD | 1064.83% |
2010 Q2 | 263 Thousand USD | -95.95% |
2010 Q1 | 6.5 Million USD | -11.49% |
2010 Q4 | 82.87 Million USD | -5.81% |
2009 Q3 | 461 Thousand USD | 19.43% |
2009 Q4 | 7.34 Million USD | 1493.06% |
2009 FY | 7 Million USD | 1802.17% |
2009 Q2 | 386 Thousand USD | -2.28% |
2009 Q1 | 395 Thousand USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | 371 Thousand USD | -4.63% |
2008 Q3 | - USD | -100.0% |
2008 FY | 368 Thousand USD | -12.38% |
2008 Q1 | 389 Thousand USD | 0.0% |
2007 Q3 | 435 Thousand USD | -17.61% |
2007 Q4 | - USD | -100.0% |
2007 Q2 | 528 Thousand USD | 196.63% |
2007 Q1 | 178 Thousand USD | 0.0% |
2007 FY | 420 Thousand USD | 104.88% |
2006 Q3 | 4000.00 USD | 0.0% |
2006 FY | 205 Thousand USD | 5025.0% |
2006 Q1 | 5000.00 USD | 25.0% |
2006 Q2 | 4000.00 USD | -20.0% |
2006 Q4 | - USD | -100.0% |
2005 Q2 | 9000.00 USD | -10.0% |
2005 FY | 4000.00 USD | -66.67% |
2005 Q4 | 4000.00 USD | -20.0% |
2005 Q3 | 5000.00 USD | -44.44% |
2005 Q1 | 10 Thousand USD | -16.67% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | -100.0% |
2004 FY | 12 Thousand USD | -28.11% |
2004 Q3 | - USD | 0.0% |
2004 Q4 | 12 Thousand USD | 0.0% |
2003 Q2 | 199.19 Thousand USD | -35.54% |
2003 Q4 | 16.69 Thousand USD | -80.91% |
2003 Q3 | 87.43 Thousand USD | -56.11% |
2003 FY | 16.69 Thousand USD | -96.0% |
2003 Q1 | 308.99 Thousand USD | -25.88% |
2002 FY | 416.87 Thousand USD | -93.41% |
2002 Q1 | 1.07 Million USD | -83.06% |
2002 Q4 | 416.87 Thousand USD | -23.38% |
2002 Q3 | 544.06 Thousand USD | -21.68% |
2002 Q2 | 694.65 Thousand USD | -35.19% |
2001 FY | 6.32 Million USD | -74.8% |
2001 Q1 | 20.93 Million USD | -16.61% |
2001 Q3 | 9.2 Million USD | -40.79% |
2001 Q2 | 15.54 Million USD | -25.75% |
2001 Q4 | 6.32 Million USD | -31.27% |
2000 Q2 | 31.91 Million USD | 3.98% |
2000 Q1 | 30.69 Million USD | -8.38% |
2000 FY | 25.1 Million USD | -25.06% |
2000 Q4 | 25.1 Million USD | -18.77% |
2000 Q3 | 30.9 Million USD | -3.17% |
1999 Q2 | 13.2 Million USD | 0.76% |
1999 Q3 | 25.2 Million USD | 90.91% |
1999 FY | 33.5 Million USD | 161.72% |
1999 Q4 | 33.5 Million USD | 32.94% |
1999 Q1 | 13.1 Million USD | 2.34% |
1998 Q1 | 10.9 Million USD | 5.83% |
1998 FY | 12.8 Million USD | 24.27% |
1998 Q2 | 10.1 Million USD | -7.34% |
1998 Q3 | 11 Million USD | 8.91% |
1998 Q4 | 12.8 Million USD | 16.36% |
1997 Q2 | 10.7 Million USD | 0.0% |
1997 Q1 | 10.7 Million USD | 0.0% |
1997 Q3 | 11.7 Million USD | 9.35% |
1997 Q4 | 10.3 Million USD | -11.97% |
1997 FY | 10.3 Million USD | -3.74% |
1996 Q4 | 10.7 Million USD | 4.9% |
1996 Q2 | 10 Million USD | 2.04% |
1996 Q1 | 9.8 Million USD | 16.67% |
1996 FY | 10.7 Million USD | 27.38% |
1996 Q3 | 10.2 Million USD | 2.0% |
1995 Q3 | 6.1 Million USD | -12.86% |
1995 Q4 | 8.4 Million USD | 37.7% |
1995 Q1 | 5.1 Million USD | 10.87% |
1995 Q2 | 7 Million USD | 37.25% |
1995 FY | 8.4 Million USD | 82.61% |
1994 Q1 | 3.8 Million USD | 65.22% |
1994 FY | 4.6 Million USD | 100.0% |
1994 Q4 | 4.6 Million USD | 2.22% |
1994 Q3 | 4.5 Million USD | 15.38% |
1994 Q2 | 3.9 Million USD | 2.63% |
1993 Q1 | 1 Million USD | 0.0% |
1993 Q3 | 1.2 Million USD | 9.09% |
1993 FY | 2.3 Million USD | 130.0% |
1993 Q4 | 2.3 Million USD | 91.67% |
1993 Q2 | 1.1 Million USD | 10.0% |
1992 FY | 1 Million USD | 900.0% |
1992 Q1 | 500 Thousand USD | 400.0% |
1992 Q2 | 600 Thousand USD | 20.0% |
1992 Q3 | 600 Thousand USD | 0.0% |
1992 Q4 | 1 Million USD | 66.67% |
1991 Q3 | 200 Thousand USD | 0.0% |
1991 FY | 100 Thousand USD | 0.0% |
1991 Q4 | 100 Thousand USD | -50.0% |
1990 FY | - USD | -100.0% |
1990 Q4 | - USD | 0.0% |
1989 Q4 | 200 Thousand USD | 0.0% |
1989 FY | 200 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -940.019% |
AngioDynamics, Inc. | 5.91 Million USD | -14972.016% |
AtriCure, Inc. | 74.49 Million USD | -1096.551% |
Avinger, Inc. | 15.39 Million USD | -5689.925% |
Azenta, Inc. | 60.43 Million USD | -1374.881% |
BioLife Solutions, Inc. | 42.69 Million USD | -1987.932% |
The Cooper Companies, Inc. | 2.56 Billion USD | 65.306% |
Daxor Corporation | 755.65 Thousand USD | -117857.835% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -12335.254% |
Femasys Inc. | 6.7 Million USD | -13202.115% |
GlucoTrack, Inc. | 196 Thousand USD | -454675.0% |
Harvard Bioscience, Inc. | 42.77 Million USD | -1983.929% |
Hologic, Inc. | 2.53 Billion USD | 64.832% |
ICU Medical, Inc. | 1.7 Billion USD | 47.712% |
Intuitive Surgical, Inc. | 89.8 Million USD | -892.605% |
KORU Medical Systems, Inc. | 4.44 Million USD | -19952.53% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -4568.023% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 8.107% |
Microbot Medical Inc. | 231 Thousand USD | -385769.697% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -12058.542% |
Nephros, Inc. | 1.83 Million USD | -48448.965% |
NovoCure Limited | 596.24 Million USD | -49.496% |
NEXGEL, Inc. | 2.79 Million USD | -31757.005% |
NEXGEL, Inc. | 2.79 Million USD | -31757.005% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -1083.932% |
OraSure Technologies, Inc. | 13.5 Million USD | -6500.703% |
Pro-Dex, Inc. | 13.54 Million USD | -6479.752% |
Pulse Biosciences, Inc. | 9.14 Million USD | -9648.021% |
Predictive Oncology Inc. | 2.85 Million USD | -31101.156% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -25853.388% |
QuidelOrtho Corporation | 2.61 Billion USD | 65.902% |
Repligen Corporation | 711.8 Million USD | -25.225% |
Sanara MedTech Inc. | 11.79 Million USD | -7458.944% |
STAAR Surgical Company | 35.83 Million USD | -2387.467% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -260531.287% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 61.228% |
Jin Medical International Ltd. | 4.11 Million USD | -21571.748% |